Rallybio Corporation (RLYB) Tops Q1 EPS by 7c

Rallybio Corporation (NASDAQ: RLYB) reported Q1 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $20 thousand.

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August